» Articles » PMID: 20208540

Programmed Death-1-induced Interleukin-10 Production by Monocytes Impairs CD4+ T Cell Activation During HIV Infection

Abstract

Viral replication and microbial translocation from the gut to the blood during HIV infection lead to hyperimmune activation, which contributes to the decline in CD4+ T cell numbers during HIV infection. Programmed death-1 (PD-1) and interleukin-10 (IL-10) are both upregulated during HIV infection. Blocking interactions between PD-1 and programmed death ligand-1 (PD-L1) and between IL-10 and IL-10 receptor (IL-10R) results in viral clearance and improves T cell function in animal models of chronic viral infections. Here we show that high amounts of microbial products and inflammatory cytokines in the plasma of HIV-infected subjects lead to upregulation of PD-1 expression on monocytes that correlates with high plasma concentrations of IL-10. Triggering of PD-1 expressed on monocytes by PD-L1 expressed on various cell types induced IL-10 production and led to reversible CD4+ T cell dysfunction. We describe a new function for PD-1 whereby microbial products inhibit T cell expansion and function by upregulating PD-1 levels and IL-10 production by monocytes after binding of PD-1 by PD-L1.

Citing Articles

Short-term antiretroviral therapy may not correct the dysregulations of plasma virome and cytokines induced by HIV-1 infection.

Ma Y, Zhang M, Wang Z, Cao L, Li Y, Wan Z Virulence. 2025; 16(1):2467168.

PMID: 39950859 PMC: 11866967. DOI: 10.1080/21505594.2025.2467168.


miR-142 deficit in T cells during blast crisis promotes chronic myeloid leukemia immune escape.

Chen F, Zhao D, Xu Y, Zhang Y, Chen M, Pathak K Nat Commun. 2025; 16(1):1253.

PMID: 39893171 PMC: 11787332. DOI: 10.1038/s41467-025-56383-y.


The Expression of Programmed Cell Death Ligand-1 and its Relationship with Infiltration, Metastasis and Prognosis in Cervical Squamous Cell Carcinoma.

Ge J, Xu X Reprod Sci. 2025; .

PMID: 39884999 DOI: 10.1007/s43032-024-01784-5.


The effects of bone marrow humoral components of B-cell acute lymphoblastic leukemia patients on natural killer cell suppression.

Tahrali I, Yucel E, Turkkan E, Aycicek A, Unuvar A, Cinar S Immunol Res. 2025; 73(1):31.

PMID: 39808387 DOI: 10.1007/s12026-024-09577-3.


T Cell Resistance: On the Mechanisms of T Cell Non-activation.

Beckers D, Jainarayanan A, Dustin M, Capera J Immune Netw. 2025; 24(6):e42.

PMID: 39801736 PMC: 11711127. DOI: 10.4110/in.2024.24.e42.


References
1.
Trautmann L, Janbazian L, Chomont N, Said E, Gimmig S, Bessette B . Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med. 2006; 12(10):1198-202. DOI: 10.1038/nm1482. View

2.
Petrovas C, Casazza J, Brenchley J, Price D, Gostick E, Adams W . PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection. J Exp Med. 2006; 203(10):2281-92. PMC: 2118095. DOI: 10.1084/jem.20061496. View

3.
Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G . PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol. 2006; 80(22):11398-403. PMC: 1642188. DOI: 10.1128/JVI.01177-06. View

4.
Ejrnaes M, Filippi C, Martinic M, Ling E, Togher L, Crotty S . Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006; 203(11):2461-72. PMC: 2118120. DOI: 10.1084/jem.20061462. View

5.
Brooks D, Trifilo M, Edelmann K, Teyton L, McGavern D, Oldstone M . Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006; 12(11):1301-9. PMC: 2535582. DOI: 10.1038/nm1492. View